Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study
Crossref DOI link: https://doi.org/10.1007/s00280-015-2709-8
Published Online: 2015-02-27
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hurwitz, Herbert I.
Smith, David C.
Pitot, Henry C.
Brill, Jeffrey M.
Chugh, Rashmi
Rouits, Elisabeth
Rubin, Joseph
Strickler, John
Vuagniaux, Gregoire
Sorensen, J. Mel
Zanna, Claudio
License valid from 2015-02-27